Clinical trial
A Randomized, Sham-Controlled Trial Investigating Low Intensity Focused Ultrasound as a Novel Treatment for Refractory Opioid Use Disorder
NCT06218706 is registered in ClinicalTrials.gov with Ali Rezai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Sham-Controlled Trial Investigating Low Intensity Focused Ultrasound as a Novel Treatment for Refractory Opioid Use Disorder
- Lead sponsor
- Ali Rezai
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 9, 2024
- Completion date
- March 1, 2028
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opioid use disorder